7th Circ. Weighs Copyright Suit Over Amylin Drug Promos

Law360, Chicago (May 28, 2015, 3:23 PM EDT) -- Consumer Health Information Corp. on Thursday urged the Seventh Circuit to revive its copyright infringement suit targeting Amylin Pharmaceuticals Inc. over patient education materials CHIC produced for the diabetes drug Byetta.

At a hearing in Chicago, an attorney for CHIC told the three-judge panel that a lower court erred in finding that its 2013 suit was time-barred under both federal copyright law and California law governing contract rescission. The company contends that it was pressured under “economic duress” to sign away the copyrights in a 2006 contract that Amylin never lived up to and that the drugmaker has been infringing the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!